Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety
- PMID: 28404501
- PMCID: PMC5476903
- DOI: 10.1016/j.puhe.2017.02.006
Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety
Abstract
Objectives: We describe the development and validation of measures of human papillomavirus (HPV)/HPV vaccination knowledge, fear/anxiety about vaccination, involvement in HPV vaccine decision-making, and self-efficacy with regard to getting the vaccine, designed to evaluate the efficacy of an intervention to affect these domains (collectively termed the HAVIQ: HPV Adolescent Vaccine Intervention Questionnaire).
Study design: Literature search, cognitive interviews and cross-sectional survey.
Methods: A literature search identified existing items that were modified for the present measures. Experts reviewed draft measures for face and content validity. Cognitive interviews with adolescents were also used to assess content validity. Adolescents completed the measures and an internal reliability analysis of each measure was performed.
Results: The four experts concurred that the measures had face validity. Cognitive interviews identified items requiring refinement. Content validity was examined with ten experts and was deemed acceptable. There were 1800 adolescents who completed the measures; Cronbach's alpha was >0.6 for three of the four measures. The four final measures are brief, comprising 25 items in total.
Conclusions: The measures are robustly developed and validity-tested. The HAVIQ may be used in research settings to evaluate adolescents' knowledge and experiences of the process of HPV vaccination in a school-based vaccination programme.
Keywords: Adolescent; Attitudes; Decision-making; Health knowledge; Papillomavirus vaccines; Practice; Reproducibility of results; Surveys and questionnaires.
Copyright © 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
References
-
- Ward K., Quinn H., Menzies R., McIntyre P. A history of adolescent school based vaccination in Australia. Commun Dis Intell Q Rep. 2013;37:E168–E174. - PubMed
-
- Australian Government Department of Health . 2017. Human papillomavirus (HPV)http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Conte... Last accessed: 01.02.2017; Available from:
-
- de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–1056. - PubMed
-
- Aubin F., Pretet J.L., Jacquard A.C., Saunier M., Carcopino X., Jaroud F. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV) Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47:610–615. - PubMed
-
- Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer J. 2007;121:621–632. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
